KospicyKorean filings in English
Filings / KS Industry Co., Ltd.

Beneficial Ownership Report (5%) — Standard Form

KS Industry Co., Ltd. · 주식등의대량보유상황보고서(일반)

SC 13D/GKOSDAQ · 101000 Filed 2026-11-17Korean original on DART

English form view 91% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Report on large shareholdings (general)

6.1

주식회사 케이에스인더스트리

0000

20261002

Report on Large Holdings of Shares, etc.

(General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control)
To: Financial Services CommissionReporting obligation date:2026-10-02
To: Korea ExchangeReport reference date:2026-11-16
Reporting person:(주)이메디슨
Summary
Issuer name(주)케이에스인더스트리Relationship to IssuerLargest Shareholder
Report TypeNew
Number of Shares Held and Holding RatioNumber of Shares HeldHolding Ratio
Previous Report--
Current Report8,782,15048.55
Shares under key agreements: number and ratioNumber of shares, etc.Ratio
Previous Report--
Current Report--
Number of voting rights and holding ratioNumber of Voting RightsHolding Ratio
Previous Report--
Current Report8,782,15048.55
Voting rights under key agreements: number and ratioNumber of Voting RightsRatio
Previous Report--
Current Report--
Reason for Report제3자배정 유상증자 참여 등에 따른 지분보유
※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission.

Part 1 Report Overview

1. Issuer information

Company Name(주)케이에스인더스트리Company code101000
Entity typeKOSDAQ-Listed CompanyTotal Issued Voting Shares (shares)18,090,203

2. Major shareholder information

a. Reporting person

(1) Reporting person overview

Report TypeNewJoint signatories
Reporting person typeDomestic corporationNationalityRepublic of Korea
Basis for Reporter Classification (only if reported as a statutory partnership or other entity)-
Name (Entity Name)Korean(주)이메디슨Chinese characters (English)e-medicine.Co.Ltd.
Address (Head Office) [Town/District Level Only]서울 강서구 강서로Date of Birth or Business Registration No., etc.484-86-01424
Occupation (business)비메모리용 및 기타 전자집적회로 제조업Relationship to IssuerLargest Shareholder
Business contact and person in chargeAffiliated company(주)이메디슨Department-
PositionCEOPhone Number010-80***
NameChen YangFax number02-000*
Email address**[email protected]

(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)

Legal formCorporation
Total Assets (or Total Assets Under Management)5,982,842,907Total Liabilities6,074,028,080
Total Equity-91,185,173Paid-in Capital530,000,000
Representative (representative or managing partner)Chen Yang
Decision-Making Body (Decision Maker)General meeting of shareholders
Largest Shareholder (Largest Investor)Chen YangLargest Shareholder Ownership (%) (Largest Investor Contribution Ratio)100

b. Specially related parties

(1) Specially related party overview

No.NameCategorySpecific Relationship to ReporterDate of Birth or Business Registration No., etc.NationalityAddress (Location)Occupation (Business)Relationship to Issuer
1이엘엠시스템(주)Domestic corporationOther385-88-00855Republic of Korea서울시 강남구 삼성로반도체 시스템Shareholder
* Address to town/district level only

(2) Details of specially related parties (for corporations, other entities, statutory or civil-law partnerships)

Legal formCorporation
Total Assets (or Total Assets Under Management)-Total Liabilities-
Total Equity136,240,000Paid-in Capital136,240,000
Representative (representative or managing partner)김인겸
Decision-Making Body (Decision Maker)General meeting of shareholders
Largest Shareholder (Largest Investor)김인겸Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)100

c. Collective investment manager

(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))

(1) Collective investment manager overview

No.NameBusiness Registration No., etc.Target collective investment vehicleNationalityAddress (Location)Remarks
-------

(2) Collective investment manager details

Legal form-
Paid-in Capital-Total Assets Under Management-
Representative-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Corporate Representative)-Largest Shareholder Stake-

3. Shares, etc. held and holding ratio

Report reference dateReporting personShares, etc.Share CertificatesTotal Issued Voting Shares (shares)
Name of HolderNumber of Specially Related PersonsNumber of Shares, etc. (shares)Ratio (%)Number of Shares (shares)Ratio (%)
Previous Report--------
This Report2026-11-16(주)이메디슨18,782,15048.558,782,15048.5518,090,203
Change8,782,15048.558,782,15048.5518,090,203

4. Purpose of holding

Impact on management control

| - 유상증자를 통한 최대주주 지위 확보 |
- 신규 이사 선임을 통한 경영권 확보
- 경영정상화를 위한 자본 조달 등 |
|---|

5. Reason for change

Method of change유상 신주 취득
Reason for changeManagement participation
Reason for Change-

Part 2 Details of Large Holdings

1. Holdings by reporting person and specially related persons

A. Holdings by type of shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Shares Held
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person(주)이메디슨484-86-014248,003,685--------8,003,68544.24
Specially Related Party이엘엠시스템(주)385-88-00855778,465--------778,4654.30
-------------
Aa1a2BCDEFG
H
Total Issued Voting Shares (I)Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H)Holding Ratio (%)
Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100Share Holding Ratio (A / I) × 100
18,090,203-48.5548.55

※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares

B. Holdings by form of holding

RelationshipName (Entity Name)Date of Birth or Business Registration No., etc.Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act)Total
No. 1No. 2No. 3No. 4No. 5No. 6No. 7Number of sharesRatio
Reporting person(주)이메디슨484-86-014248,003,685------8,003,68544.24
Specially Related Party이엘엠시스템(주)385-88-00855778,465------778,4654.30
-----------
※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them

2. Contracts on shares held

A. Contract status

Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.)
None

*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported

B. Contract details

No.Name (Entity Name)Relationship to ReporterDate of Birth or Business Registration No., etc.Type of shares, etc.Number of shares, etc.CounterpartyContract typeContract date (amendment date)Contract periodRatioRemarks
------------
Total (number of shares, etc.)-Total (ratio)--

C. Additional details if the main contract is a security agreement

No.Number of shares, etc.Loan amountDebtorInterest rateCollateral maintenance ratioOther
-------

3. Holdings by proprietary and customer account (financial institutions only)

NameRelationship to ReporterBy accountTotal
Own Account (shares)Ratio (%)Customer account (shares)Ratio (%)Total (shares)Ratio (%)
--------
Total------

Part 3 Material Changes Since Last Report Date

1. Summary of changes

a. Changes in shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Changes in Shares, etc.
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person(주)이메디슨484-86-014248,003,685--------8,003,68544.24
Specially Related Party-------------
-------------

2. Change details

a. Detailed changes in shares, etc.

(Unit: shares, KRW)
Name (Entity Name)Date of Birth or Business Registration No., etc.Change Date*Acquisition/disposal methodType of shares, etc.Change detailsAcquisition/disposal unit price**Remarks
Before ChangeChangeAfter Change
(주)이메디슨484-86-014242026-10-02유상신주취득(+)Voting Shares-4,885,9934,885,9931,228--
(주)이메디슨484-86-014242026-10-29유상신주취득(+)Voting Shares4,885,9933,117,6928,003,6851,283--

* For trades on the securities market, the contract date

** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities

3. Source of acquisition funds

(1) Overview of acquisition funds

(Unit: KRW)
NameDate of birth or business registration no., etc.Own funds (H)Borrowings (I)Other (J)Total (H+I+J)
(주)이메디슨484-86-0142410,000,000,000--10,000,000,000

(2) Origin and source of acquisition funds

ㅇ If own funds

NameDate of birth or business registration no., etc.Source and Formation of Acquisition Funds
(주)이메디슨484-86-01424기관 및 개인투자자 등 모집